by Xcellerant Ventures | Oct 21, 2021 | Portfolio Company News
Content origionally posted on Mayo Clinic’s blog: https://newsnetwork.mayoclinic.org/discussion/alumni-eyes-on-the-patient/ Editor’s Note: This article is the first in the Young Innovators series, originally published in Mayo Clinic’s Alumni...
by Xcellerant Ventures | Oct 13, 2021 | Portfolio Company News
Content origionally from PR News wire: https://www.prnewswire.com/news-releases/john-shufeldt-md-joins-tesis-labs-board-of-directors-301398790.html PHOENIX, Oct. 13, 2021 /PRNewswire/ — Tesis Labs, a leader in targeted genetic sequencing, announced today the...
by Xcellerant Ventures | Oct 5, 2021 | Portfolio Company News
Content origionally from PR Newsire: https://www.prnewswire.com/news-releases/tesis-labs-raises-20-million-in-growth-equity-capital-to-expand-clinical-capacity-301392610.html PHOENIX, Oct. 5, 2021 /PRNewswire/ — Tesis Labs, a leader in targeted genetic...
by Xcellerant Ventures | Aug 10, 2021 | Portfolio Company News
Origionally on Business Wire: https://www.businesswire.com/news/home/20210810005333/en/Tesis-Labs-and-Personal-Genome-Diagnostics-Announce-Collaboration-to-Advance-Cancer-Profiling-and-Treatment BALTIMORE & HOUSTON–(BUSINESS WIRE)–Tesis Labs, a...
by Xcellerant Ventures | Jul 8, 2021 | Portfolio Company News
Origionally posted on DeepLook Medical’s Website: https://www.deeplookmedical.com/post/fda-clears-one-click-segmentation-measurement-tool The FDA has granted 510(k) clearance for DL PreciseTM, our one-click tool to automate segmentation and measurement of...
